Embodied AI & Humanoid Robots Investment 2026 (Mid-Year Refresh)
FutureX Research · AI Lab · 2026.06.23 · 24 pp · preview 6 pp
Listen · Audio Summary
5-8 min · AI narration in English · abstract + all key findings
Abstract
(Data updated to Aug 1, 2026) This refresh brings the report current through August 1. Three threads accelerated in late July. On mass production, MIIT maintained its guidance that China's full-year humanoid output could exceed 100,000 units, while Tesla's Q2 call confirmed zero Optimus output to date with the Fremont line still being installed, and Figure surpassed 350 Figure 03 deliveries, deploying into BMW's Spartanburg plant. On capital markets, Unitree set Aug 5 book-building and Aug 10 subscription, Dobot cleared its listing hearing, and Anthropic reportedly began investor meetings targeting an October Nasdaq debut. On the "brain" layer, Moonshot opened Kimi K3's 2.8-trillion-parameter weights on July 26, then reportedly raised $3.5B at a $35B post-money valuation. Upstream, compute and power constraints moved to the fore. Compiled from public information; not investment advice.
Key Findings
- 01Unitree enters the final stretch: after IPO registration took effect July 2 (104 days from acceptance, a STAR Market record), it announced Aug 5 book-building and Aug 10 subscription, offering ~40.46M shares (10% post-issue) to raise RMB 4.2B at an implied ~RMB 42B valuation; institutions see potential for a RMB 100B market cap post-listing. Dobot cleared its Shenzhen hearing in late July; Leju is in inquiry; DeepRobotics is under review.
- 02Production guidance lands: at the WAIC press conference in early July, MIIT projected China's 2026 humanoid output could exceed 100,000 units (vs ~14,400 China shipments in 2025; ~18,000-20,000 globally); Goldman raised its 2026 China shipment forecast from 28,000 to 50,000. Q1 robot exports reached RMB 11.32B, with humanoid exports up 210% YoY.
- 03Overseas ramp reality check: Tesla's July 22 Q2 call confirmed zero Optimus output to date with the Fremont line still being installed; the 2026 target is 50,000-100,000 units, with first units used for training-data collection, not customer delivery. Musk called it "the hardest product to scale manufacturing" in Tesla's history. Figure has delivered 350+ Figure 03 units; BotQ phase one is rated at 12,000 units/year, and Figure 03 now runs logistics sequencing at BMW Spartanburg.
- 04The brain-cost collapse materializes: Moonshot released the 2.8-trillion-parameter Kimi K3 on July 16 (KDA hybrid linear attention, 1M-token context) and opened full weights on July 26 EDT, a day early, under a modified MIT license; it then reportedly closed a $3.5B round at a $35B post-money valuation, with a pre-IPO round planned for August at a rumored valuation of up to $50B and a Hong Kong Chapter 18C listing in view.
- 05Capital-market stratification accelerates: Anthropic reportedly filed a confidential S-1 on June 1, with bankers scheduling investor meetings since mid-July for a Nasdaq debut as early as October at a reported ~$965B valuation; DeepSeek is reportedly preparing an IPO with valuations cited between roughly RMB 350B and 500B across sources. The gap between primary-market narrative premium and public-market delivery pricing keeps widening.
- 06Compute and energy move upstream: Bloomberg reported July 22 that OpenAI plans to spend over $30B on a Georgia data center with 3.2GW of secured power, phasing in from 2028; Musk's xAI acquired APR Energy (~$1B, over 1GW of mobile turbines; closed in May per an FTC filing, surfacing mid-July). Power is becoming the binding upstream constraint for AI and embodied intelligence.
I. The Mass-Production Inflection (Part 1): 100,000-Unit Guidance and the Export Story
At the WAIC press conference in early July, MIIT officials projected that China's full-year humanoid robot output could exceed 100,000 units in 2026 — against roughly 14,400 China shipments in 2025 (18,000-20,000 globally), marking the shift from "can build" to "can mass-produce." Investment banks are more conservative: Goldman Sachs raised its 2026 China shipment forecast from 28,000 to 50,000 units, while UBS sits near 30,000. The gap between guidance and forecasts is itself the key variable to verify in H2. On exports, Q1 robot exports reached RMB 11.32B, with humanoid exports up 210% YoY across 148 countries and regions. The event calendar is dense: WAIC (Shanghai, opened July 17) drew 1,100+ companies, 3,000+ exhibits and 300+ global debuts, with production-grade machines and live automotive/logistics lines taking center stage; the World Robot Conference (Beijing Yizhuang, Aug 19-23) will bring 150+ more debuts and a global application-exploration program matching mass-produced robots to real-world scenarios.
I. The Mass-Production Inflection (Part 2): China's Capacity Race Goes Five Figures
China's leading players have moved from hundreds to tens of thousands of units. AgiBot's 15,000th general-purpose embodied robot rolled off the line in late June — three years ago its annual output was six units; its self-built "A-Chain" standardized supply chain claims order-driven flexible capacity above 100,000 units/year, targeting shipments in the tens of thousands for 2026. Scenario validation is advancing in parallel: eight Genie G2 robots ran a six-day livestreamed deployment on Longcheer's production line in June, independently handling high-precision inspection tasks at a 99.99% success rate. Unitree shipped 5,500+ humanoids in 2025, ranking first globally; at WAIC it unveiled the new H2 (1.82m, 70kg, 3-hour endurance) and the dual-arm R1 series — priced below RMB 30,000 — alongside the GD01 rideable transforming mech. Leju posted RMB 258M in 2025 revenue with a three-year CAGR of 118.68%, pursuing a price-for-volume ChiNext listing. Falling prices plus rising capacity are turning humanoids from demos into industrial goods.
I. The Mass-Production Inflection (Part 3): Tesla and Figure — a Ramp Reality Check
The overseas leaders' actual ramps matter more than their marketing. Tesla dismantled Fremont's Model S/X line in 46 days to install the first-generation Optimus line, and Musk was on site July 1 confirming it was operational; but the July 22 Q2 call disclosed revenue up 26% YoY with profit nearly halved — and confirmed Optimus output of zero as of the call. Musk conceded Optimus has ~10,000 all-new parts requiring a supply chain built from scratch, calling it "the hardest product to scale manufacturing" in Tesla's history; the official 2026 target is 50,000-100,000 units, with first units used for training-data collection rather than customer delivery. Figure's cadence is more concrete: 350+ Figure 03 units delivered, ramping from one per day toward roughly one per hour; BotQ phase one is rated at 12,000 units/year, targeting 100,000 over four years. Since late June, Figure 03 has run logistics sequencing at BMW Spartanburg, where Figure 02 previously supported body-shop work on 30,000 X3s. Another barrier-lowering signal: NVIDIA's Isaac GR00T reference humanoid (Jetson Thor + Unitree H2 Plus), unveiled in June, ships via Unitree late this year.
Key Questions
When is Unitree's IPO subscription, and at what valuation?
Unitree set book-building for Aug 5, 2026 and subscription for Aug 10, offering about 40.46 million shares (10% post-issue) to raise RMB 4.2 billion at an implied valuation of roughly RMB 42 billion. Registration took effect July 2 — just 104 days from acceptance, a STAR Market record — and institutions see potential for a RMB 100 billion market cap after listing.
How many humanoid robots will be produced in 2026, and where does Tesla Optimus stand?
In early July MIIT projected China's 2026 humanoid output could exceed 100,000 units (vs ~14,400 China shipments in 2025), and Goldman raised its 2026 China forecast from 28,000 to 50,000 units. Tesla's July 22 Q2 call confirmed zero Optimus output to date with the Fremont line still being installed, against a 2026 target of 50,000-100,000 units; Figure has delivered 350+ Figure 03 units, now working at BMW Spartanburg.
Is Kimi K3 open-sourced, and what is Moonshot AI's latest valuation?
Yes. Moonshot released the 2.8-trillion-parameter Kimi K3 on July 16 (KDA hybrid linear attention, 1M-token context) and opened full weights on July 26 — a day early — under a modified MIT license. It then reportedly closed a $3.5 billion round at a $35 billion post-money valuation, with a pre-IPO round planned for August at a rumored valuation of up to $50 billion and a Hong Kong Chapter 18C listing in view.
Watch & Listen
▶ The Next Inflection in the AI RaceYouTube · needs VPN in ChinaIn China: search WeChat Channels 「倩姐投AI」; full library → Qian on AI
Sourcing and standards
Compiled from public sources; data current as of 2026.06.23. The text separates verified facts, reported claims, our own estimates and disputed points, and states the derivation behind every estimate. When we get something wrong, the correction is written into the report body with the original call left visible, and logged publicly.
Research standards and corrections log →📄 Full Report
Full report: 24 pages · provided to professional investors & partners only
The above is a public preview. The full version includes the sections below; per compliance it is not posted publicly and is not free to download — please contact a FutureX colleague to request it.
- 🔒II. Capital Markets: The IPO Window Opens Wide — Unitree's Countdown and the Valuation Rift
- 🔒III. The "Brain" Layer: Kimi K3 Weights Land Early and Brain Costs Collapse
- 🔒IV. AI Hardware Wars: Apple v. OpenAI and Spillover Signals from the Giants
- 🔒V. Compute and Energy: 3.2GW Power Deals and Mobile Turbines — the Hidden Upstream Bottleneck
- 🔒VI. Value Chain Map: Who Benefits, in a Neutral Framework
- 🔒VII. Risk Factors: Zero Output, Price Wars and Diverging Forecasts
Related Research
Embodied Intelligence / Physical AI
CES 2026 and Year One of Physical AI
Private Markets / Exits
The 2026 AI Exit Wave: A Midyear Review of the Strongest Exit Window on Record
Quantum Computing × AI
Quantum Computing × AI 2026: The Error-Correction Inflection, IPO Window, and the New Compute-Energy Constraint
Industry research from FutureX Capital's AI Lab, compiled from public information; not investment advice; contains no fund performance, AUM, or offer to raise capital.